Alamar Biosciences 的 NULISA 數據將於 AAIC 2026 上超過 140 場科學簡報會中亮相，突顯基於血液的阿茲海默症生物標記剖析之最新進展

ConferenceNULISAeMTBR-TauBD-pTau217Positive

AI Analysis

Summary

Alamar Biosciences will present NULISA data and host a scientific workshop on eMTBR-Tau and BD-pTau217 biomarkers at AAIC 2026, showcasing progress in blood-based Alzheimer's disease detection and staging biomarkers.

Outcome Details

NULISA data to be presented at AAIC 2026 in over 140 scientific presentations; company hosting scientific workshop on eMTBR-Tau and BD-pTau217 research data

Importance:4/10

Sentiment:

0.40

conference presentationbiomarkersAlzheimer's diseaseblood-based testingAAIC 2026

Related Companies

$ALMR

Read the original article

Published by GlobeNewswire Clinical Studies on July 10, 2026 11:24 PM

Read Original